45 results
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
16 Aug 23
Current report (foreign)
9:25pm
invested in the corporate governance process. Registered shareholders and duly appointed proxyholders will be able to attend, participate and vote
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
16 Aug 23
Current report (foreign)
9:25pm
in the Meeting, which is consistent with the goals of the regulators, stakeholders, and others invested in the corporate governance process. Registered
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
12 Jul 23
Current report (foreign)
12:00am
with the applicable listing and corporate governance rules and regulations of the Nasdaq.
(b) As of the date hereof, the Common Shares are registered pursuant
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
2 Jun 23
Current report (foreign)
4:03pm
Simon G. Best (OBE) Chair, Human Resources & Corporate Governance Committee Timothy S. Wach Director DR. GARY BRIDGER Director Eugene Siklos Director
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
2 May 23
Notice of Annual Meeting of Shareholders
4:19pm
Nominees
Compensation
Statement of Corporate Governance Practices
Board Mandate
Independence
Chair of the Board & Lead Independent Director
Directors … Committee
External Auditors
The HR & Corporate Governance Committee
Standing Committees' Charters
Other Committees
The Science and Technology Committee
6-K
EX-99.2
8gkqhk
2 May 23
Notice of Annual Meeting of Shareholders
4:19pm
6-K
EX-99.1
gahvlk1b2og ki2piw1
15 Dec 22
Notice of Special Meeting of Shareholders
4:03pm
6-K
EX-99.1
llr jcalzez6e1h
1 Sep 22
Liminal BioSciences Announces Listing Transfer to Nasdaq Capital Market
4:37pm
6-K
EX-99.1
pu9dfbqcp6pz0dlwp1g
3 May 22
Notice of Annual Meeting of Shareholders
8:32am
6-K
EX-99.1
3m0lbnsb6wzbpgo2
4 May 21
Notice of Annual and Special Meeting of Shareholders
5:05pm
424B3
rdersk4chck8ugd7
11 Dec 20
Prospectus supplement
12:00am
424B3
h1je5 mexdcr4vctdt
10 Dec 20
Prospectus supplement
9:53pm
F-3
51whm
2 Dec 20
Shelf registration (foreign)
12:00am
POS AM
f2zy48xi h6
2 Dec 20
Prospectus update (post-effective amendment)
12:00am
F-3
zvs29nk
1 Dec 20
Shelf registration (foreign)
4:48pm
424B3
rac5q1a20u5tgstq85k
12 Nov 20
Prospectus supplement
5:21pm
6-K
EX-99.6
m41kvo
12 Nov 20
Liminal BioSciences Reports Third Quarter Financial Results
5:07pm
424B3
h1az ef5351
30 Sep 20
Prospectus supplement
5:14pm